Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions caused by tissue stress and inflammation, including neuropathic pain and ...

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented ...

VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to ...

A burning sensation in the feet is usually harmless and temporary; however if it is chronic it can be due to various ...

Neuros Medical announced today that it closed an oversubscribed Series D financing round worth $56 million in proceeds.

The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

Moreover, SciatiEase Reviews frequently highlight inconsistent results: some customers report modest improvements in Sciatic ...

Tissium announced today that it received FDA de novo marketing authorization for Coaptium Connect with Tissium Light.

The FDA has granted de novo marketing authorisation to TISSIUM’s COAPTIUM CONNECT, representing the first atraumatic option for repairing peripheral nerve damage.

The surgical sealant developer Tissium obtained a groundbreaking FDA clearance for its method of reconnecting severed nerves, ...

THE WOODLANDS, Texas, June 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that data from a study evaluating the impact of sotagliflozin on hypoglycemia in people ...